LYKA LABS
Back to Cashflow Statement
|
LYKA LABS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹1.77 Cr | ₹8.95 Cr | ₹79 Cr | ₹8.81 Cr | ₹5.32 Cr |
What is the latest Cash Flow from Operating Activities ratio of LYKA LABS ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹1.77 Cr |
Mar2023 | ₹8.95 Cr |
Mar2022 | ₹79 Cr |
Mar2021 | ₹8.81 Cr |
Mar2020 | ₹5.32 Cr |
How is Cash Flow from Operating Activities of LYKA LABS Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹1.77 Cr | -80.20 | |
Mar2023 | ₹8.95 Cr | -88.70 | |
Mar2022 | ₹79 Cr | 799.30 | |
Mar2021 | ₹8.81 Cr | 65.55 | |
Mar2020 | ₹5.32 Cr | - |
Compare Cash Flow from Operating Activities of peers of LYKA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LYKA LABS | ₹426.3 Cr | 3.8% | 8.4% | 14.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,865.0 Cr | -0.5% | -8.4% | 14.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,574.0 Cr | -2.4% | 7.2% | 50.6% | Stock Analytics | |
CIPLA | ₹118,710.0 Cr | -0.7% | -3.7% | -1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹105,964.0 Cr | -1.4% | -3.9% | 19% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,232.0 Cr | 0.5% | 5.6% | 5.1% | Stock Analytics |
LYKA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LYKA LABS | 3.8% |
8.4% |
14.1% |
SENSEX | -1% |
1.4% |
7.9% |
You may also like the below Video Courses